DK2531233T3 - PATTERN HOLDER, PHARMACEUTICAL SUPPLY AND PROCEDURE FOR KEEPING A CARTRIDGE IN A CARTRIDGE - Google Patents
PATTERN HOLDER, PHARMACEUTICAL SUPPLY AND PROCEDURE FOR KEEPING A CARTRIDGE IN A CARTRIDGE Download PDFInfo
- Publication number
- DK2531233T3 DK2531233T3 DK11703167.4T DK11703167T DK2531233T3 DK 2531233 T3 DK2531233 T3 DK 2531233T3 DK 11703167 T DK11703167 T DK 11703167T DK 2531233 T3 DK2531233 T3 DK 2531233T3
- Authority
- DK
- Denmark
- Prior art keywords
- cartridge
- drug delivery
- delivery device
- coupling housing
- fixing member
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 4
- 238000012377 drug delivery Methods 0.000 claims description 51
- 230000008878 coupling Effects 0.000 claims description 50
- 238000010168 coupling process Methods 0.000 claims description 50
- 238000005859 coupling reaction Methods 0.000 claims description 50
- 238000006073 displacement reaction Methods 0.000 claims description 18
- JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 50
- 108010011459 Exenatide Proteins 0.000 description 47
- 229960001519 exenatide Drugs 0.000 description 47
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 22
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 21
- 229940079593 drug Drugs 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- QEFRNWWLZKMPFJ-YGVKFDHGSA-N L-methionine S-oxide Chemical compound CS(=O)CC[C@H](N)C(O)=O QEFRNWWLZKMPFJ-YGVKFDHGSA-N 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000003055 low molecular weight heparin Substances 0.000 description 3
- 229940127215 low-molecular weight heparin Drugs 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000001831 (C6-C10) heteroaryl group Chemical group 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010037003 Buserelin Proteins 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 description 1
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 102400000932 Gonadoliberin-1 Human genes 0.000 description 1
- 108010069236 Goserelin Proteins 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101500026183 Homo sapiens Gonadoliberin-1 Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 108010021717 Nafarelin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 108010010056 Terlipressin Proteins 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 108010050144 Triptorelin Pamoate Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- CUWODFFVMXJOKD-UVLQAERKSA-N buserelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 CUWODFFVMXJOKD-UVLQAERKSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229960004281 desmopressin Drugs 0.000 description 1
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005153 enoxaparin sodium Drugs 0.000 description 1
- 229960001442 gonadorelin Drugs 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 229960002913 goserelin Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- RWHUEXWOYVBUCI-ITQXDASVSA-N nafarelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 RWHUEXWOYVBUCI-ITQXDASVSA-N 0.000 description 1
- 229960002333 nafarelin Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960004532 somatropin Drugs 0.000 description 1
- 229960003813 terlipressin Drugs 0.000 description 1
- BENFXAYNYRLAIU-QSVFAHTRSA-N terlipressin Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CN)CSSC1 BENFXAYNYRLAIU-QSVFAHTRSA-N 0.000 description 1
- CIJQTPFWFXOSEO-NDMITSJXSA-J tetrasodium;(2r,3r,4s)-2-[(2r,3s,4r,5r,6s)-5-acetamido-6-[(1r,2r,3r,4r)-4-[(2r,3s,4r,5r,6r)-5-acetamido-6-[(4r,5r,6r)-2-carboxylato-4,5-dihydroxy-6-[[(1r,3r,4r,5r)-3-hydroxy-4-(sulfonatoamino)-6,8-dioxabicyclo[3.2.1]octan-2-yl]oxy]oxan-3-yl]oxy-2-(hydroxy Chemical compound [Na+].[Na+].[Na+].[Na+].O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1O)NC(C)=O)O[C@@H]1C(C[C@H]([C@@H]([C@H]1O)O)O[C@@H]1[C@@H](CO)O[C@H](OC2C(O[C@@H](OC3[C@@H]([C@@H](NS([O-])(=O)=O)[C@@H]4OC[C@H]3O4)O)[C@H](O)[C@H]2O)C([O-])=O)[C@H](NC(C)=O)[C@H]1C)C([O-])=O)[C@@H]1OC(C([O-])=O)=C[C@H](O)[C@H]1O CIJQTPFWFXOSEO-NDMITSJXSA-J 0.000 description 1
- 229960004824 triptorelin Drugs 0.000 description 1
- VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
- A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M2005/2433—Ampoule fixed to ampoule holder
- A61M2005/2437—Ampoule fixed to ampoule holder by clamping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M2005/2485—Ampoule holder connected to rest of syringe
- A61M2005/2488—Ampoule holder connected to rest of syringe via rotation, e.g. threads or bayonet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10152219 | 2010-02-01 | ||
| PCT/EP2011/051306 WO2011092326A1 (en) | 2010-02-01 | 2011-01-31 | Cartridge holder, drug delivery device and method for securing a cartridge in a cartridge holder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2531233T3 true DK2531233T3 (en) | 2019-03-11 |
Family
ID=42262054
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11703167.4T DK2531233T3 (en) | 2010-02-01 | 2011-01-31 | PATTERN HOLDER, PHARMACEUTICAL SUPPLY AND PROCEDURE FOR KEEPING A CARTRIDGE IN A CARTRIDGE |
| DK18193393.8T DK3427779T3 (da) | 2010-02-01 | 2011-01-31 | Patronholder, lægemiddeladministrationsanordning og fremgangsmåde til fastholdelse af en patron i en patronholder |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18193393.8T DK3427779T3 (da) | 2010-02-01 | 2011-01-31 | Patronholder, lægemiddeladministrationsanordning og fremgangsmåde til fastholdelse af en patron i en patronholder |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9775949B2 (enExample) |
| EP (3) | EP3427779B1 (enExample) |
| JP (1) | JP6006642B2 (enExample) |
| KR (1) | KR101772855B1 (enExample) |
| CN (2) | CN104474610B (enExample) |
| AU (1) | AU2011209472B2 (enExample) |
| BR (1) | BR112012019144A2 (enExample) |
| CA (1) | CA2786861A1 (enExample) |
| DE (1) | DE202011111021U1 (enExample) |
| DK (2) | DK2531233T3 (enExample) |
| IL (1) | IL221092A (enExample) |
| MX (1) | MX2012008836A (enExample) |
| MY (1) | MY166695A (enExample) |
| NZ (1) | NZ601496A (enExample) |
| RU (1) | RU2557896C2 (enExample) |
| SG (1) | SG183127A1 (enExample) |
| TR (1) | TR201902092T4 (enExample) |
| WO (1) | WO2011092326A1 (enExample) |
| ZA (1) | ZA201204752B (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2786861A1 (en) | 2010-02-01 | 2011-08-04 | Sanofi-Aventis Deutschland Gmbh | Cartridge holder, drug delivery device and method for securing a cartridge in a cartridge holder |
| EP2601992A1 (en) | 2011-12-08 | 2013-06-12 | Sanofi-Aventis Deutschland GmbH | Syringe carrier |
| US8834449B2 (en) | 2012-01-23 | 2014-09-16 | Ikomed Technologies, Inc. | Mixing syringe |
| US9751056B2 (en) | 2012-01-23 | 2017-09-05 | Merit Medical Systems, Inc. | Mixing syringe |
| EP2806922B1 (en) | 2012-01-25 | 2018-09-19 | Novo Nordisk A/S | Drug delivery device with cartridge fixation feature |
| MX2014009976A (es) | 2012-02-24 | 2014-09-08 | Novo Nordisk As | Dispositivo de suministro de farmaco con caracteristica de carga frontal. |
| IN2014KN02875A (enExample) * | 2012-05-29 | 2015-05-08 | Carebay Europe Ltd | |
| UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| JP6408998B2 (ja) | 2012-12-21 | 2018-10-17 | サノフイＳａｎｏｆｉ | 二重ｇｌｐ１／ｇｉｐまたは三方ｇｌｐ１／ｇｉｐ／グルカゴンアゴニスト |
| EP2777684A1 (en) | 2013-03-14 | 2014-09-17 | Sanofi-Aventis Deutschland GmbH | Medicament container carrier and adapter |
| JP6316945B2 (ja) | 2013-05-21 | 2018-04-25 | ノボ・ノルデイスク・エー／エス | ピストンロッド結合具を有する薬剤送達装置 |
| EP2999502A1 (en) | 2013-05-21 | 2016-03-30 | Novo Nordisk A/S | Frontloaded drug delivery device with dynamic axial stop feature |
| CN105209094A (zh) | 2013-05-21 | 2015-12-30 | 诺和诺德股份有限公司 | 具有致动型筒保持器和活塞杆联轴器的前载型药物输送装置 |
| EP3569271A1 (en) * | 2013-10-18 | 2019-11-20 | Sanofi-Aventis Deutschland GmbH | Injection device |
| WO2015086730A1 (en) | 2013-12-13 | 2015-06-18 | Sanofi | Non-acylated exendin-4 peptide analogues |
| WO2015086728A1 (en) | 2013-12-13 | 2015-06-18 | Sanofi | Exendin-4 peptide analogues as dual glp-1/gip receptor agonists |
| EP3080149A1 (en) | 2013-12-13 | 2016-10-19 | Sanofi | Dual glp-1/glucagon receptor agonists |
| TW201609799A (zh) | 2013-12-13 | 2016-03-16 | 賽諾菲公司 | 雙重ｇｌｐ－１／ｇｉｐ受體促效劑 |
| TW201625668A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物 |
| TW201625669A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑 |
| TW201625670A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑 |
| US9932381B2 (en) | 2014-06-18 | 2018-04-03 | Sanofi | Exendin-4 derivatives as selective glucagon receptor agonists |
| FR3036968A1 (fr) | 2015-06-02 | 2016-12-09 | Biocorp Prod | Boitier de montage d'un recipient sur un stylo injecteur, ensemble formant reservoir de produit injectable pour un stylo injecteur et stylo injecteur equipe d'un tel ensemble |
| FR3036969A1 (fr) * | 2015-06-02 | 2016-12-09 | Biocorp Prod | Procede de fabrication d'au moins un ensemble formant reservoir, ensemble formant reservoir de produit injectable pour un stylo injecteur et stylo injecteur equipe d'un tel ensemble |
| TW201709941A (zh) | 2015-06-03 | 2017-03-16 | 賽諾菲阿凡提斯德意志有限公司 | 聲響指示器（二） |
| TW201709940A (zh) | 2015-06-03 | 2017-03-16 | 賽諾菲阿凡提斯德意志有限公司 | 聲響指示器（一） |
| TW201700117A (zh) | 2015-06-03 | 2017-01-01 | 賽諾菲阿凡提斯德意志有限公司 | 用於自動注射器的注射筒托架和組裝方法 |
| TW201707744A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置（二） |
| TW201705994A (zh) | 2015-06-03 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 自動注射器及組裝方法 |
| TW201700118A (zh) | 2015-06-03 | 2017-01-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置（三） |
| TW201711713A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置（五） |
| TW201707737A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置（一） |
| AR105319A1 (es) | 2015-06-05 | 2017-09-27 | Sanofi Sa | Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico |
| US10792433B2 (en) * | 2015-07-01 | 2020-10-06 | Ipsen Pharma | Syringe assembly |
| TW201706291A (zh) | 2015-07-10 | 2017-02-16 | 賽諾菲公司 | 作為選擇性肽雙重ｇｌｐ－１／升糖素受體促效劑之新毒蜥外泌肽（ｅｘｅｎｄｉｎ－４）衍生物 |
| USD822203S1 (en) * | 2015-12-01 | 2018-07-03 | Gerresheimer Bunde Gmbh | Frontal geometry of a syringe |
| AT518320B1 (de) * | 2016-02-10 | 2018-07-15 | Ait Austrian Inst Tech Gmbh | Vorrichtung zur Bestimmung des Füllstandes in einer Karpule |
| EP3871707A1 (en) * | 2016-06-15 | 2021-09-01 | Bayer Healthcare LLC | Syringe for a multi-use disposable system |
| WO2018007103A1 (en) * | 2016-07-06 | 2018-01-11 | Carebay Europe Ltd. | Device for a medicament container |
| US20180034183A1 (en) * | 2016-07-27 | 2018-02-01 | Tyco Electronics Corporation | Electrical connector with integrated anti-decoupling features |
| US10583255B2 (en) * | 2016-07-27 | 2020-03-10 | Shl Medical Ag | Medicament container assembly for a medicament delivery device |
| JP6871428B2 (ja) | 2017-05-25 | 2021-05-12 | ウエスト ファーマスーティカル サービシーズ インコーポレイテッド | 近距離無線通信と静電容量の検出とを利用したコンピュータ制御の注射器 |
| EP3687605B1 (en) * | 2017-09-29 | 2024-12-11 | West Pharmaceutical Services, Inc. | Housing with syringe holding feature |
| DK3703784T3 (da) | 2017-11-03 | 2025-11-24 | Sanofi Sa | Anordning til indgivelse af lægemidler |
| EP3703783B1 (en) | 2017-11-03 | 2025-01-08 | Sanofi | Drug delivery device |
| EP3597237A1 (en) * | 2018-07-18 | 2020-01-22 | Sanofi | Cartridge assembly for a drug delivery device and drug delivery device |
| US20200054833A1 (en) * | 2018-08-20 | 2020-02-20 | Marcus Gregory Romanello | Fluid dispensing apparatus |
| JP7744906B2 (ja) * | 2019-12-18 | 2025-09-26 | サノフイ | 薬物送達デバイスのためのカートリッジアセンブリおよび薬物送達デバイス |
| WO2022066921A1 (en) * | 2020-09-25 | 2022-03-31 | Becton, Dickinson And Company | Friction fit component for cartridges and medical injection device including the same |
| EP4070832A1 (en) * | 2021-04-07 | 2022-10-12 | medmix Switzerland AG | Keyed connectors |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1814466A1 (de) * | 1968-12-13 | 1970-06-25 | Hoechst Ag | Einmalspritze |
| US5088996A (en) * | 1984-04-16 | 1992-02-18 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
| US4781701A (en) * | 1986-07-11 | 1988-11-01 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Syringe for medical purposes |
| US5002537A (en) * | 1989-10-23 | 1991-03-26 | Gte Products Corporation | Hypodermic syringe |
| WO1992004926A1 (en) | 1990-09-21 | 1992-04-02 | Novo Nordisk A/S | Adaptor top |
| DK228290D0 (da) * | 1990-09-21 | 1990-09-21 | Novo Nordisk As | An injektion unit |
| EP0680767A1 (en) * | 1994-05-06 | 1995-11-08 | Nardino Righi | Non-reusable safety syringe |
| JP3383966B2 (ja) * | 1994-05-27 | 2003-03-10 | ニプロ株式会社 | プレフィルドシリンジ |
| US5549575A (en) * | 1994-09-13 | 1996-08-27 | Becton Dickinson And Company | Cartridge retainer assembly for medication delivery pen |
| US5921966A (en) * | 1997-08-11 | 1999-07-13 | Becton Dickinson And Company | Medication delivery pen having an improved clutch assembly |
| WO1999016485A1 (en) | 1997-09-29 | 1999-04-08 | Becton Dickinson And Company | Injection device and drug cartridge for preventing cross-use of the device and drug cartridge |
| US6036675A (en) * | 1999-02-03 | 2000-03-14 | Specialized Health Products, Inc. | Safety sterile cartride unit apparatus and methods |
| RU26292U1 (ru) * | 2002-04-29 | 2002-11-27 | Федеральный научно-производственный центр закрытое акционерное общество "Научно-производственный концерн (объединение) "ЭНЕРГИЯ" | Устройство для послеоперационного дренажа |
| CN100358593C (zh) * | 2002-08-29 | 2008-01-02 | 诺沃挪第克公司 | 前装式注射装置 |
| US6932794B2 (en) * | 2003-04-03 | 2005-08-23 | Becton, Dickinson And Company | Medication delivery pen |
| DK1715904T3 (en) * | 2004-02-18 | 2015-11-30 | Ares Trading Sa | Handheld electronically controlled injection device for injection of liquid drugs |
| GB2420713B (en) * | 2004-12-01 | 2007-12-19 | Jih-Hsiung Yang | Safe syringe |
| CA2595069C (en) | 2005-01-18 | 2011-05-03 | Wockhardt Americas Inc | Pen shaped medication injection devices |
| WO2007104636A1 (en) * | 2006-03-10 | 2007-09-20 | Novo Nordisk A/S | An injection device and a method of changing a cartridge in the device |
| EP2040783B1 (en) | 2006-07-11 | 2010-06-09 | Eli Lilly & Company | Needle mounting assembly for a medication injection device |
| WO2008071804A1 (en) * | 2006-12-15 | 2008-06-19 | Novo Nordisk A/S | A medical delivery system comprising a container and a dosing assembly with radially moving fastening means |
| CN101600468B (zh) * | 2006-12-21 | 2012-12-12 | 诺沃-诺迪斯克有限公司 | 注射器装置 |
| WO2009137486A1 (en) | 2008-05-05 | 2009-11-12 | Becton, Dickinson And Company | Drug delivery device having cartridge with enlarged distal end |
| CN102245237B (zh) * | 2008-12-12 | 2014-05-28 | Shl集团有限责任公司 | 传送构件附接装置 |
| JP5563075B2 (ja) * | 2009-07-31 | 2014-07-30 | エス・ホー・エル・グループ・アクチボラゲット | 薬剤容器ホルダ構成 |
| CA2786861A1 (en) | 2010-02-01 | 2011-08-04 | Sanofi-Aventis Deutschland Gmbh | Cartridge holder, drug delivery device and method for securing a cartridge in a cartridge holder |
-
2011
- 2011-01-31 CA CA2786861A patent/CA2786861A1/en not_active Abandoned
- 2011-01-31 NZ NZ601496A patent/NZ601496A/en not_active IP Right Cessation
- 2011-01-31 JP JP2012550470A patent/JP6006642B2/ja active Active
- 2011-01-31 KR KR1020127022580A patent/KR101772855B1/ko active Active
- 2011-01-31 EP EP18193393.8A patent/EP3427779B1/en active Active
- 2011-01-31 MY MYPI2012002870A patent/MY166695A/en unknown
- 2011-01-31 DK DK11703167.4T patent/DK2531233T3/en active
- 2011-01-31 SG SG2012057030A patent/SG183127A1/en unknown
- 2011-01-31 WO PCT/EP2011/051306 patent/WO2011092326A1/en not_active Ceased
- 2011-01-31 AU AU2011209472A patent/AU2011209472B2/en not_active Ceased
- 2011-01-31 EP EP20194772.8A patent/EP3782677A1/en active Pending
- 2011-01-31 CN CN201410737061.6A patent/CN104474610B/zh active Active
- 2011-01-31 BR BR112012019144A patent/BR112012019144A2/pt not_active IP Right Cessation
- 2011-01-31 CN CN201180007998.2A patent/CN102740909B/zh active Active
- 2011-01-31 DK DK18193393.8T patent/DK3427779T3/da active
- 2011-01-31 RU RU2012137269/14A patent/RU2557896C2/ru not_active IP Right Cessation
- 2011-01-31 DE DE202011111021.8U patent/DE202011111021U1/de not_active Expired - Lifetime
- 2011-01-31 EP EP11703167.4A patent/EP2531233B1/en active Active
- 2011-01-31 TR TR2019/02092T patent/TR201902092T4/tr unknown
- 2011-01-31 MX MX2012008836A patent/MX2012008836A/es unknown
- 2011-01-31 US US13/575,353 patent/US9775949B2/en active Active
-
2012
- 2012-06-26 ZA ZA2012/04752A patent/ZA201204752B/en unknown
- 2012-07-24 IL IL221092A patent/IL221092A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012137269A (ru) | 2014-03-10 |
| MX2012008836A (es) | 2012-09-07 |
| EP2531233A1 (en) | 2012-12-12 |
| NZ601496A (en) | 2013-12-20 |
| KR20120114385A (ko) | 2012-10-16 |
| EP2531233B1 (en) | 2018-11-21 |
| CN104474610B (zh) | 2018-09-14 |
| US20130046245A1 (en) | 2013-02-21 |
| MY166695A (en) | 2018-07-18 |
| AU2011209472B2 (en) | 2014-07-24 |
| CN104474610A (zh) | 2015-04-01 |
| SG183127A1 (en) | 2012-09-27 |
| AU2011209472A1 (en) | 2012-08-23 |
| EP3427779B1 (en) | 2020-11-25 |
| DK3427779T3 (da) | 2021-02-15 |
| IL221092A (en) | 2015-04-30 |
| CA2786861A1 (en) | 2011-08-04 |
| CN102740909B (zh) | 2016-05-04 |
| JP6006642B2 (ja) | 2016-10-12 |
| US9775949B2 (en) | 2017-10-03 |
| EP3782677A1 (en) | 2021-02-24 |
| ZA201204752B (en) | 2013-02-27 |
| HK1208636A1 (en) | 2016-03-11 |
| CN102740909A (zh) | 2012-10-17 |
| JP2013517870A (ja) | 2013-05-20 |
| RU2557896C2 (ru) | 2015-07-27 |
| DE202011111021U1 (de) | 2018-05-02 |
| TR201902092T4 (tr) | 2019-03-21 |
| KR101772855B1 (ko) | 2017-08-31 |
| EP3427779A1 (en) | 2019-01-16 |
| BR112012019144A2 (pt) | 2016-10-04 |
| WO2011092326A1 (en) | 2011-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2531233T3 (en) | PATTERN HOLDER, PHARMACEUTICAL SUPPLY AND PROCEDURE FOR KEEPING A CARTRIDGE IN A CARTRIDGE | |
| US9492619B2 (en) | Assembly for a drug delivery device and drug delivery device | |
| US8740860B2 (en) | Assembly for a drug delivery device and drug delivery device | |
| US9974906B2 (en) | Assembly for a drug delivery device and drug delivery device | |
| EP2482879B1 (en) | Method and assembly for a drug delivery device | |
| US9533104B2 (en) | Assembly for a drug delivery device and piston rod | |
| HK40036896A (en) | Drug delivery device with cartridge holder | |
| HK40002297A (en) | Cartridge holder, drug delivery device and method for securing a cartridge in a cartridge holder | |
| HK40002297B (en) | Cartridge holder, drug delivery device and method for securing a cartridge in a cartridge holder | |
| US8721604B2 (en) | Assembly for a drug delivery device and drug delivery device | |
| HK1208636B (zh) | 药筒保持器、给药装置和用於将药筒固定在药筒保持器中的方法 | |
| HK1178826B (en) | Assembly for a drug delivery device and drug delivery device |